Health Bulletin 8/September/2022

Here are the top health news for the day:

MCC NEET PG 2022 counselling tentative schedule released, check out details

The Medical Counselling Committee (MCC) has released the tentative counselling schedule for PG medical admissions process for this academic year.

As per the schedule, the round one registrations for the NEET PG 2022 counselling will begin on September 15th, the choice filling facility will be available from September 20th to 25th. Processing of seat allotment will be done from 26th to 27th September and the result will be declared on 28th September. The reporting will be done from 29th September to 4th October.

For more details, check out the link given below:

MCC NEET PG 2022 Counselling Tentative Schedule Released, Check Out Details

AYUSH medicos to undergo clinical training at modern medicine hospitals, Colleges: AP Gazette

Through a recent gazette, the Andhra Pradesh Government has allowed the students of AYUSH courses to undergo clinical training at modern medicine hospitals and medical colleges.

While the State had already given its nod for the matter, the Commissioner of AYUSH had earlier requested to give permission to the students and interns of some more AYUSH colleges for undergoing clinical and Non-clinical training in the Allopathic hospitals.

For more details, check out the link given below:

AYUSH Medicos To Undergo Clinical Training At Modern Medicine Hospitals, Colleges: AP Gazette

BDS in India: Duration changed to 5.5 Years, mandatory internship, credit based system introduced

After MBBS, now major modifications are going to be introduced in the undergraduate dental education too with the introduction of new Draft Bachelor of Dental Surgery (BDS) course regulations, which increases the course duration to five-and-a-half years and includes a mandatory one-year internship and a semester system following the footsteps of medical education.

As per the new Draft Regulations, apart from the mandatory internship and semester based evaluation system, a competency-based approach has been proposed for addressing the outcomes of the training. In the new system, credit hours shall be assigned to each courses and choice based credits would be available for the students so that they get to pick certain electives. Besides, the Draft also has proposed the concept of credit transfer among colleges.

For more details, check out the link given below:

BDS In India: Duration Changed To 5.5 Years, Mandatory Internship, Credit Based System Introduced

NEET UG result 2022 Declared

The National Testing Agency (NTA) has declared the Result/NTA Scores/Rank of National Eligibility cum Entrance Test (UG) 2022.

National Testing Agency conducts the NEET (UG) since 2019 with the approval of the Ministry of Health and Family Welfare and the Ministry of Education, in pursuance of the direction of the Hon'ble Supreme Court of India.

National Testing Agency conducted the National Eligibility cum Entrance Test (UG) for 1872343 candidates at 3570 different Centres located in 497 Cities throughout the country including 14 Cities outside India on 17 July 2022 (Sunday) from 02:00 P.M. to 05:20 P.M. (IST).

For more details, check out the link given below:

NEET 2022 Results Declared

Researchers warn about rising cancer cases among adults under 50 years of age

Over recent decades, more and more adults under the age of 50 are developing cancer. A study conducted by researchers from Brigham and Women's Hospital, a founding member of Mass General Brigham, reveals that the incidence of early onset cancers (those diagnosed before age 50), including cancers of the breast, colon, esophagus, kidney, liver, and pancreas among others, has dramatically increased around the world, with this drastic rise beginning around 1990. 

Ugai T et al. "Is early-onset cancer an emerging global epidemic? Current evidence and future implications." Nature Reviews Clinical Oncology DOI: 10.1038/s41571-022-00672-8

Setback: HC rejects Sun Pharma plea against hetero alleging trademark infringement of cancer drug Letroz

Holding that when the name is derived or coined from the name of the principal ingredient being used in the manufacture of the drug, no distinctiveness or exclusiveness can be claimed by the manufacturer, the Delhi High Court has rejected an appeal by drug major Sun Pharma against Hetero Healthcare alleging infringement of its trade mark Letroz, a generic drug for second line treatment of advanced breast cancer.

A division bench of Justices Vibhu Bakhru and Amit Mahajan upheld the decision of the Commercial Court that noted that it was apparent that the mark adopted by Sun Pharma was nothing but the first six letters of the ingredient, 'Letrozole', which is the international non-proprietary name (INN) of a salt.

For more details, check out the link given below:

Setback: HC Rejects Sun Pharma Plea Against Hetero Alleging Trademark Infringement Of Cancer Drug Letroz